Market revenue in 2022 | USD 367.3 million |
Market revenue in 2030 | USD 687.2 million |
Growth rate | 8.1% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.47% in 2022. Horizon Databook has segmented the UK dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of dry eye diseases in the UK is one of the major factors driving the market growth. According to data published by eyecare expert, Théa UK, it is estimated that 34% of the total population in the UK, representing one in every three people, is diagnosed with dry eye disease.
Dry eye disease risk factors include using contact lenses, staring at screens for extended periods without a break, being in air-conditioned or warm environments, smoking, and consuming alcohol. Moreover, healthcare organizations and government authorities are working together in the UK to organize campaigns to spread awareness about eye conditions.
There was a launch of the first-ever UK National Eye-health program to formulate policies that will help the population and government to reduce the cost burden of eye diseases in the country. The UK government has separate budget provisions for eye conditions.
Horizon Databook provides a detailed overview of country-level data and insights on the UK dry eye syndrome treatment market , including forecasts for subscribers. This country databook contains high-level insights into UK dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account